The present invention relates to pharmaceutical compositions comprising furan-2-sulfonamide derivatives. The present invention further relates to methods of treatment of diseases or conditions associated with endothelial lipase activity, including coronary artery disease and low HDL-C.
申请公布号
EP3055289(A1)
申请公布日期
2016.08.17
申请号
EP20140851805
申请日期
2014.10.06
申请人
TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION;SHIFA BIOMEDICAL CORPORATION
发明人
ABOU-GHARBIA, MAGID;CHILDERS, WAYNE E.;MARTINEZ, ROGELIO L.;GHIDU, VICTOR P.;ELSHOURBAGY, NABIL;MEYERS, HAROLD;MOUSA, SHAKER A.